Dilantin vs generic phenytoin sodium
Medical Letter on Drugs and Therapeutics 22(12): 49-50
1980
ISSN/ISBN: 0025-732X PMID: 7374622 Document Number: 166072
Document emailed within 1 workday
Related Documents
Jefferys, R.J. 2005: Lower phenytoin serum levels in persons switched from brand to generic phenytoin Neurology 65(4): 657-8; Author Reply 657-8Suthisisang, C.; Payakachat, N.; Chulavatnatol, S.; Towanabut, S. 1998: Bioavailability of phenytoin sodium capsules available in Thailand. Part II: in vivo study Journal of the Medical Association of Thailand 81(1): 64-70
Kuo, C.C.; Bean, B.P. 1994: Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons Molecular Pharmacology 46(4): 716-725
Suthisisang, C.; Payakachat, N. 1998: Bioavailability of phenytoin sodium capsules available in Thailand. Part I: In vitro study Journal of the Medical Association of Thailand 81(1): 58-63
Colburn, W.A.; Gibaldi, M. 1978: Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(4): 452-455
Levy, R.H.; Moreland, T.A. 1984: Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions Schweizerische Rundschau für Medizin Praxis 73(6): 159-163
Rastogi, P.; Mehrotra, T.N.; Agarwala, R.K.; Singh, V.S. 1991: Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy Journal of the Association of Physicians of India 39(8): 606-608
Song, S.; Cheng, T.; Lin, Y. 1999: Influence of modulatory activity of wound fluid on the characteristics of fibroblasts from irradiation and the action of phenytoin sodium Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 13(1): 47-50
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Kim, C. 1990: Dilantin toxicity and depression Archives of Physical Medicine and Rehabilitation 71(12): 1024
Heling, B.; Blumenfeld, I. 1976: Gingival hypertrophy associated with dilantin Harefuah 90(12): 577-578
Bathla, S.; Suneja, A.; Guleria, K.; Agarwal, N. 2002: Dilantin as anticonvulsant in eclampsia Journal of the Indian Medical Association 100(9): 561-564
Spivak, D.L. 1989: The action of dilantin on the state of consciousness Fiziologiia Cheloveka 15(4): 16-23
Gertenrich, R.L.; Brown, C.A. 1974: Treatment of Dilantin gingival hyperplasia with Proxigel American Journal of Mental Deficiency 78(4): 502-504
Mack, R.B. 1984: Medical exorcism--acute dilantin intoxication North Carolina Medical Journal 45(2): 99-100
Huang, J.S.; Ho, K.Y.; Chen, C.C.; Wu, Y.M.; Wang, C.C.; Ho, Y.P.; Liu, C.S. 1997: Collagen synthesis in idiopathic and dilantin-induced gingival fibromatosis Kaohsiung Journal of Medical Sciences 13(3): 141-148
Tucker, M.S.; Fitzharris, J.W. 1985: Dilantin-induced erythema multiforme major: report of a case with liver and kidney involvement Journal of the American Osteopathic Association 85(8): 511-514